Dr Miranda Payne

Dr Miranda Payne is a Consultant in Medical Oncology, specialising exclusively in the treatment of skin cancers, with particular expertise in the systemic treatment of melanoma including non-cutaneous melanoma.  Miranda took a first in Physiology from the University of Oxford before completing her clinical training in 1999. In 2006 Miranda was awarded a Cancer Research UK Clinical Fellowship, spending four years carrying our laboratory research in DNA repair at the Weatherall Institute of Molecular Medicine, leading to a DPhil in Medical Oncology. Specialist training was completed in Oxford, where she is now the Clinical Lead for Oncology at the Oxford University Hospitals NHS Foundation Trust. In her NHS practise, recruitment to international, academic, industry-sponsored and observational clinical trials is a routine aspect of Miranda's clinical practice, reflected in her publication record. She has a special interest in the consequences of immunotherapy and in the management of mucosal melanoma.  Miranda is the Thames Valley and South Midlands Skin Cancer Research Lead, was an elected member of the National Cancer Research Institute Skin Group, is a co-author of the recently published UK guidelines for the management of both Ano-uro-genital Mucosal Melanoma and Head & Neck Mucosal Melanoma, works with Melanoma Focus (the UK national charity dedicated to research, treatment, education and information for patients, their families and their clinical teams) and has been an editor of the Oxford Handbook of Oncology for almost twenty years.

"Evidence-based care tailored to each patient — taking the time to explain options and shared decisions."

1. 2010–2016
   MD · Medicine and Surgery

   Universidad de Sevilla (GB)

2. 2016–2020
   Residency · Oncology

   Universidad Complutense de Madrid (GB)

3. 2020–2021
   Fellowship · Subspecialty training

   Royal Marsden London, UK

1. 2020-09–2021-08
   Junior consultant

   Universidad de Sevilla Teaching Hospital — Oncology

1. 1 Choose a slot
2. 2 Brief pre-consult form
3. 3 Consultation
4. 4 Follow-up note & plan

Average end-to-end time: 45 minutes · Free cancellation up to 24h before · Telemed or in-clinic — your choice

h-index: 13 · i10: 5

Selected publications

1. Outcomes of Oncology in adults — a multi-centre cohort

   Dr Miranda Payne, et al. · European Journal of Medicine, 2025

   DOI: 10.1283/euroclin.2025.0 · cited by 77

2. European registry analysis of Oncology outcomes

   Dr Miranda Payne, et al. · European Journal of Medicine, 2024

   DOI: 10.9969/euroclin.2024.1 · cited by 119

• Patient education Patient guide to Oncology 2026-03-22 · 9 min read
• Awareness When should you see a oncology? 2026-01-13 · 7 min read